INTERNATIONAL PATENT: ODYSSEY THERAPEUTICS, INC. FILES APPLICATION FOR "CRYSTALLINE FORMS OF N-(1-(TERT-BUTYL)-1H-PYRAZOL-4-YL)-2-(4-((6-((METHYLSULFONYL)QUINOLIN-4-YL)OXY)-3-METHYLPHENYL)ACETAMIDE AND SALTS THEREOF AS RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES"

GENEVA, Dec. 10 -- ODYSSEY THERAPEUTICS, INC. (51 Sleeper St., Suite 800Boston, MA 02210) filed a patent application (PCT/US2025/031212) for "CRYSTALLINE FORMS OF N-(1-(TERT-BUTYL)-1H-PYRAZOL-4-YL)-2-(4-((6-((METHYLSULFONYL)QUINOLIN-4-YL)OXY)-3-METHYLPHENYL)ACETAMIDE AND SALTS THEREOF AS RIPK2 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES" on May 28, 2025. With publication no. WO/2025/250650, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KOELMEL, Dominik, K. (950 Greene Street, Unit 228Ann Arbor, MI 48104), VANH...